Cy-TB test introduced by Kerala govt. for detecting and treating tuberculosis
TB infection is different from active TB disease. A person with TB infection harbours the organism causing TB infection (Mycobacterium tuberculosis) in the body, having probably acquired it through contact with someone with active disease. But the organism remains dormant or inactive in the body and the person neither has any TB symptoms nor is he contagious.
However, if left untreated, 5-10% of them will progress to developing active TB disease when the body's immune system weakens, allowing the TB bacteria to flare up. This could happen within weeks of acquiring the infection or maybe years, depending on the immune system and other factors determining immune regulation.
Study
A community-based cross-sectional study among adults in Thiruvananthapuram district in 2023 had reported that roughly one-fifth of the adult population in the district – 20.5% of adults – have tuberculosis infection. The study, 'Prevalence of Tuberculosis Infection among Adults of Thiruvananthapuram District of Kerala as Measured by Interferon Gamma Release Assay – A Cross-Sectional Study,' tested whole blood samples of 396 adults in Thiruvananthapuram for TB infection and found that the prevalence of TB infection increased with age, ranging from 11.5% in the 18-35 age group to 30.3% in the 58-years-plus age group.
'Our studies show that about 22% of the State's general population has acquired TB infection from the community. While they pose no immediate threat to the community, once they go into an immuno-compromised state, the bacteria will multiply and produce symptoms of active disease. Given the morbidity profile of Kerala – high prevalence of diabetes, chronic kidney disease, heavy alcohol use and a huge population on dialysis – it is important that we identify and treat these people to reduce the future burden of TB,' says Aparna Mohan, Government of India-WHO consultant for TB.
Cy-TB is a third generation test approved by the Central TB Division.
Blood test detection
Since 2021, Kerala has been using the blood test Interferon Gamma Release Assay (IGRA) for detecting TB infection. However, this test required extensive laboratory support and it had a waiting period too. There were also systemic difficulties in rolling it out.
Cy-TB is a highly specific, accurate and user-friendly skin test, wherein 0.1 ml dose of M. tuberculosis-specific antigens (ESAT-6 and CFP-10) are injected into the skin in the inner forearm. An induration (a raised area) of 5 mm or more which develops on the skin within 48-72 hours indicates TB infection (While a trained nurse can administer the injection, the person will have to return to the health centre for checking out the skin reaction.)
If tested positive, active TB has to be ruled out before considering TB preventive therapy. TB preventive therapy is optional and not currently recommended for all those who are infected. Only high risk individuals recommended for preventive therapy under the NTEP alone need to take preventive therapy.
Risk groups
In Kerala, the identified risk groups include individuals on immunosuppressive therapy, those with silicosis (lung disease following the inhalation of silica dust), those on anti-TNF treatment, and those on dialysis and awaiting organ transplantation. Preventive therapy is also offered to health-care workers who test positive in the Cy-TB test.
The preventive therapy is a short regimen with less number of drugs. This could be three-month weekly Isoniazid and Rifapentine (3HP) or six-months daily Isoniazid (6H).
According to the State TB Division, Cy-TB will be offered in district TB centres, taluk hospitals, at the block level in some districts and in all dialysis centres too. The Health department also intends to use Cy-TB to test inmates in old age homes where pulmonary TB has been reported. The test is currently available in major private hospitals too.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
44 minutes ago
- India.com
Good news! Now you can get insurance for low price, get Rs 2 lakh cover for only Rs 20 in this govt scheme, name is….
Good news! Now you can get insurance for low price, get Rs 2 lakh cover for only Rs 20 in this govt scheme, name is…. Get Rs 2 lakh insurance for just a cost of two tea cups. Know about Pradhan Mantri Suraksha Bima Yojana here. By Joy Pillai Edited by Joy Pillai Advertisement Good news! Now you can get insurance for low price, get Rs 2 lakh cover for only Rs 20 in this govt scheme, name is.... Pradhan Mantri Suraksha Bima Yojana: Many people have a habit of drinking tea and smoking cigarettes. This habit affects health and, in the long run, causes serious diseases. But what if we tell you that you can buy insurance worth Rs 2 lakh just by skipping two cups of tea or a cigarette? Today, we are telling you about an insurance scheme that provides financial security at a very low premium. No, it is not a fraud scheme, and there are no hidden charges either, because the scheme is run by the Government of India. The name of this scheme is Pradhan Mantri Suraksha Bima Yojana (PMSBY). Let's know more about the scheme. What Is Pradhan Mantri Suraksha Bima Yojana? Pradhan Mantri Suraksha Bima Yojana is basically an accident insurance scheme which offers accidental death and disability cover on account of an accident. The aim of the scheme is to provide financial strength to economically weaker families. The premium under PMSBY is only Rs. 20 per year. Under this scheme, you can also deposit a premium of Rs. 2 every month. Under this scheme, this amount is deducted from your Aadhaar linked bank account every year. Advertisement === Key Features Of PMSBY If the insured person becomes completely disabled in an accident, then he is eligible to get Rs 2 lakh. In case of a partial accident, Rs 1 lakh is given under the scheme. Advertisement === The insurance can be renewed every year. If the policyholder dies, then this money is given to the family. Who Can Avail The Benefit? People between the ages of 18 to 70 can avail themselves of the benefits of the scheme. Notably, this policy ends automatically on completion of the age of 70 years. Only Indian citizens are eligible for the security insurance scheme. The applicant must have an active bank account in any bank, which is linked to Aadhaar. If your bank account is closed then this policy will also end. The policy cover period is between 1st June to 31st May. What Is The Process Of Applying? To apply for this insurance program, apply at your bank. The bank will provide an application form which, once completed and submitted with the required documents, will initiate the process.
News18
16 hours ago
- News18
Nearly 3 in 5 Indians Choose Makhanas As Their Go-To Healthy Snack, Reveals Report
Over 55% of those surveyed said they actively seek snacks that are clean and preservative-free, says report India's leading wholesome snacking brand, Farmley, unveiled the second edition of its flagship Healthy Snacking Report at the Indian Healthy Snacking Summit (IHSS) 2025 held in New Delhi. Drawing insights from respondents across generations, professions and cities, the 2025 report presents a vivid picture of how India snacks today, blending tradition with modernity, taste with functionality, and indulgence with health consciousness. The report reveals that Indian consumers are no longer willing to settle for bland 'healthy" snacks or feel guilt over indulgent treats. Over 55% of those surveyed said they actively seek snacks that are clean and preservative-free. These trends indicate a major shift toward functional snacking, where every bite aligns with wellness goals. Packaging has also become a major purchase driver. 52% of respondents said they prefer resealable, eco-conscious packaging. Makhanas and flavoured dry fruits are leading this revolution in format. Roasted and flavoured dry fruits have emerged as the most preferred savoury snack, with 36% favouring them, while 19% of respondents specifically chose makhana, showing its successful transition into a modern-day super-snack. This growing popularity aligns with the Government of India's recent announcement of establishing a Makhana Board in Bihar under Union Budget 2025-26. Interestingly, while newer formats are gaining traction, legacy choices such as chips and wafers still hold ground with 14% choosing them, followed by namkeen and multigrain snacks like khakhras at 10% and 9% respectively. Sweet snacks too are evolving. While chocolate continues to reign as India's all-time favourite, nutty flavours like peanut butter, hazelnut, and pistachio are now preferred for their blend of taste and health. Speaking on the findings, Akash Sharma, co-founder, Farmley, said 'This year's report reflects a clear evolution. From snacking out of habit to snacking with purpose. Consumers today are seeking flavour and functionality in every bite, and are no longer willing to compromise between taste and trust. That's where Farmley leads, creating guilt-free indulgences that people feel good about choosing." Snacking habits are also being reshaped by lifestyle changes. Nearly 45% of consumers now prefer on-the-go snack formats like dry fruit-based desserts and energy bars that are portable, clean-label, and functional. This is particularly reflective of India's growing urban workforce, where desk-side indulgence is expected to deliver on both convenience and conscious consumption. Brand loyalty, once concentrated around legacy players, is now diversifying through multiple channels. While traditional offline aisles dominate for discovery and planned purchases, quick commerce and influencer-led content has driven a surge in impulse snacking, especially among Gen Z and millennials who order packaged snacks weekly at double the rate of older consumers (43% vs 28%). Meanwhile, Tier 2 and Tier 3 cities are increasingly embracing regional players who, despite lacking national advertising muscle, build deep trust through consistent quality and community presence. This shift signals a broader cultural change where transparency, reliability, and local connection matter as much as flavour and marketing reach. While taste remains king, the wave of health consciousness we saw in last year's report seems to have held, with more consumers shunning mindless munching for wholesome, nutritious options. view comments First Published: July 19, 2025, 13:32 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
The Hindu
17 hours ago
- The Hindu
Cy-TB test introduced by Kerala govt. for detecting and treating tuberculosis
The State health authorities in Kerala have introduced a new intradermal test called Cy-TB for detecting and treating tuberculosis (TB) infection following the prioritisation of latent TB infection treatment under the National TB Elimination Programme (NTEP). TB infection is different from active TB disease. A person with TB infection harbours the organism causing TB infection (Mycobacterium tuberculosis) in the body, having probably acquired it through contact with someone with active disease. But the organism remains dormant or inactive in the body and the person neither has any TB symptoms nor is he contagious. However, if left untreated, 5-10% of them will progress to developing active TB disease when the body's immune system weakens, allowing the TB bacteria to flare up. This could happen within weeks of acquiring the infection or maybe years, depending on the immune system and other factors determining immune regulation. Study A community-based cross-sectional study among adults in Thiruvananthapuram district in 2023 had reported that roughly one-fifth of the adult population in the district – 20.5% of adults – have tuberculosis infection. The study, 'Prevalence of Tuberculosis Infection among Adults of Thiruvananthapuram District of Kerala as Measured by Interferon Gamma Release Assay – A Cross-Sectional Study,' tested whole blood samples of 396 adults in Thiruvananthapuram for TB infection and found that the prevalence of TB infection increased with age, ranging from 11.5% in the 18-35 age group to 30.3% in the 58-years-plus age group. 'Our studies show that about 22% of the State's general population has acquired TB infection from the community. While they pose no immediate threat to the community, once they go into an immuno-compromised state, the bacteria will multiply and produce symptoms of active disease. Given the morbidity profile of Kerala – high prevalence of diabetes, chronic kidney disease, heavy alcohol use and a huge population on dialysis – it is important that we identify and treat these people to reduce the future burden of TB,' says Aparna Mohan, Government of India-WHO consultant for TB. Cy-TB is a third generation test approved by the Central TB Division. Blood test detection Since 2021, Kerala has been using the blood test Interferon Gamma Release Assay (IGRA) for detecting TB infection. However, this test required extensive laboratory support and it had a waiting period too. There were also systemic difficulties in rolling it out. Cy-TB is a highly specific, accurate and user-friendly skin test, wherein 0.1 ml dose of M. tuberculosis-specific antigens (ESAT-6 and CFP-10) are injected into the skin in the inner forearm. An induration (a raised area) of 5 mm or more which develops on the skin within 48-72 hours indicates TB infection (While a trained nurse can administer the injection, the person will have to return to the health centre for checking out the skin reaction.) If tested positive, active TB has to be ruled out before considering TB preventive therapy. TB preventive therapy is optional and not currently recommended for all those who are infected. Only high risk individuals recommended for preventive therapy under the NTEP alone need to take preventive therapy. Risk groups In Kerala, the identified risk groups include individuals on immunosuppressive therapy, those with silicosis (lung disease following the inhalation of silica dust), those on anti-TNF treatment, and those on dialysis and awaiting organ transplantation. Preventive therapy is also offered to health-care workers who test positive in the Cy-TB test. The preventive therapy is a short regimen with less number of drugs. This could be three-month weekly Isoniazid and Rifapentine (3HP) or six-months daily Isoniazid (6H). According to the State TB Division, Cy-TB will be offered in district TB centres, taluk hospitals, at the block level in some districts and in all dialysis centres too. The Health department also intends to use Cy-TB to test inmates in old age homes where pulmonary TB has been reported. The test is currently available in major private hospitals too.
